Trial intelligence / Profile preview

Postoperative analgesia with continuous ropivacaine infiltration after lumbar spine arthrodesis

2008-004705-34Phase 4Completed

Sponsor
Centre Hospitalier Universitaire de Nice
Start
Sep 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in Lumbar Spinal Disease (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Postoperative pain evolution up to day 2. Started Sep 2008; status: completed.

02

Drugs

ropivacaine
03

Conditions

Lumbar Spinal Disease

Beyond the preview

Go deeper on 2008-004705-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004705-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call